Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Chi Town 7 - morning review

Shares in companies who signed up for an MMP license would become an asset of PTSC hence enhance the overall asset and income base for PTSC's shareholders. Fundamental growth with PARTNERS for the future, an increasing income and share ownership of the market using MMP technology will take PTSC to a very strong position in cash and assets...........

Share
New Message
Please login to post a reply